RUBEXAL

This brand name is authorized in Ecuador

Active ingredients

The drug RUBEXAL contains a combination of these active pharmaceutical ingredients (APIs):

1 Camphora
UNII N20HL7Q941 - CAMPHOR (NATURAL)
Read about Camphora
2 Benzocaine
UNII U3RSY48JW5 - BENZOCAINE

Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited.

Read about Benzocaine
3 Menthol
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
Read about Menthol
4 Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

Read about Methyl salicylate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M02AX10 Various M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AX Other topical products for joint and muscular pain
Discover more medicines within M02AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 050005-MAN-10-07

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.